Press Releases

CNS Provides FDA Update on IND Filing

Aug 25, 2020 8:39am EDT

CNS Pharmaceuticals Engages CRO For Phase 2 Berubicin Clinical Trials

Aug 20, 2020 8:00am EDT

CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020

Aug 11, 2020 8:00am EDT

CNS Pharmaceuticals Recognizes Glioblastoma Awareness Day

Jul 22, 2020 8:00am EDT

CNS Pharmaceuticals Completes Drug Product Manufacturing Strategy for Berubicin

Jul 15, 2020 8:00am EDT

CNS Pharmaceuticals Completes Active Ingredient Shipments to Manufacturers

Jul 08, 2020 8:00am EDT

CNS Pharmaceuticals Engages Berry Consultants to Advise Phase 2 Trial Design

Jun 30, 2020 8:00am EDT

CNS To Present at the Life Sciences Investor Forum

Jun 23, 2020 8:00am EDT

CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin

Jun 11, 2020 8:00am EDT

CNS Announces Highlights from Annual Meeting of Shareholders

Jun 09, 2020 8:00am EDT